Get 25% off on 1st online pharmacy purchase. Use Code: NEW2026
From:
$13.06

Prescription required

Doxepin Hydrochloride(Sinequan): Uses, Dosage, Side Effects, and More

From:
$13.06

Prescription required

Doxepin hydrochloride is an oral psychotropic prescription medication belonging to the dibenzoxepin class of tricyclic compounds. Functioning primarily as a tricyclic antidepressant (TCA), doxepin possesses unique structural and pharmacological properties that differentiate it from alternative TCAs.

Clinically, doxepin oral capsules and tablets are indicated for the treatment of:

  • Major Depressive Disorder (MDD): Particularly depression accompanied by prominent anxiety, psychomotor agitation, or severe psychic tension.
  • Anxiety States: Generalized anxiety or anxiety associated with organic disease, neurosis, or chronic alcoholism.
  • Psychotic Depressive States: Often deployed as an internal component of a multi-modal psychiatric regimen.

Because of its potent antihistaminic properties, low-dose doxepin (3-mg and 6-mg tablets) is also highly effective in addressing chronic sleep-maintenance insomnia. The higher-strength capsule and tablet formulations detailed here are primarily designated for therapeutic psychiatric management.

Your Prescription

Ready to Fill

Need Help?

Our pharmacists are available 24/7 to answer questions about your medication.

Drug Facts

Generic name

Doxepin

Brand names

Sinequan, Silenor

Drug type

Tricyclic antidepressant (TCA)

Controlled substance

Not a controlled medication

Dosage forms

Oral capsules, oral solution, oral tablets (low-dose tablets for insomnia)

Typical dosage

Adults typically take doxepin by mouth once daily or in divided doses depending on the condition being treated. For depression and anxiety, treatment commonly starts at 25–75 mg per day, with gradual adjustments based on response and tolerability; usual maintenance doses range from 75–150 mg daily. For insomnia (low-dose formulations), adults typically take 3–6 mg once daily within 30 minutes of bedtime. Doxepin may cause drowsiness and should be taken exactly as prescribed. Tablets and capsules should not be stopped abruptly without medical guidance.

Mechanism

Mechanism of Action and Pharmacokinetics

Pharmacodynamics

Doxepin acts as a complex neurochemical modulator. Rather than targeting a single receptor site, it exerts widespread effects across multiple central and peripheral neurotransmitter systems:

  • Monoamine Reuptake Inhibition: Doxepin inhibits the presynaptic reuptake pumps for serotonin ($5\text{-HT}$) and norepinephrine ($\text{NE}$). By blocking these transporters, it extends the residence time of these monoamines within the synaptic cleft, downstream modulating neuroplasticity and elevating mood.
  • Histamine-1 ($H_1$) Receptor Antagonism: Doxepin displays an extraordinarily high affinity for the $H_1$ receptor—surpassing many commercial over-the-counter antihistamines. This profound antagonism is responsible for the drug’s marked sedating and anxiolytic properties.
  • Muscarinic ($M_1$) and Alpha-1 ($\alpha_1$) Adrenergic Antagonism: The compound acts as a competitive antagonist at muscarinic acetylcholine receptors (causing classic anticholinergic effects) and alpha-1 receptors (causing peripheral vasodilation).

Pharmacokinetics

  • Metabolism & Active Metabolite: Doxepin undergoes extensive first-pass hepatic metabolism via the cytochrome P450 pathway. It is demethylated primarily by CYP2C19, CYP2D6, and CYP1A2 into its primary active metabolite, nordoxepin (desmethyldoxepin). Nordoxepin is a highly potent inhibitor of norepinephrine reuptake and possesses an extended biological footprint.
  • Biological Half-Life ($t_{1/2}$):
    • Parent compound (Doxepin): 6 to 17 hours
    • Active metabolite (Nordoxepin): 18 to 46 hours
  • Elimination: Primarily renal, with water-soluble metabolites excreted in the urine. Steady-state plasma concentrations can take up to a week to fully stabilize.

Dosage

Dosing, Administration, and Clinical Titration

Doxepin dosing must be highly individualized, carefully tailored to the patient’s age, symptom severity, formulation preference, and concurrent medical conditions.

Standard Titration and Maintenance

  • Initial Drowsiness Strategy: In outpatients with mild-to-moderate anxiety and depression, a conservative starting dose of 25-50 mg orally once daily at bedtime (using capsules or tablets) is commonly used to mitigate daytime somnolence and optimize sleep hygiene.
  • Therapeutic Target Range: The typical maintenance dose is 75-150 mg daily. For patients with severe or refractory psychiatric conditions, the dose may be cautiously titrated up to a maximum of 300 mg daily.
  • Dosing Schedules: Daily doses of 150 mg or less can be consolidated into a single bedtime dose using appropriate tablet or capsule strengths. Doses exceeding 150 mg should be split into divided doses throughout the day to prevent acute orthostatic hypotension.

Treatment Discontinuation

Doxepin therapy must never be abruptly stopped. Abrupt cessation of capsules or tablets can trigger a cholinergic rebound syndrome, characterized by severe nausea, vomiting, hyperhidrosis (sweating), vivid dreams, headache, and acute insomnia. Tapering schedules should be deployed gradually over several weeks under direct clinical oversight.

Get The Right Dose For Less

Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.

Side Effects

Side Effects, Risks, and Safety Warnings

Boxed Warning: Suicidality and Antidepressant Drugs

Antidepressants, including tricyclic compounds, carry an increased risk of suicidal thinking, behavior, and ideation in children, adolescents, and young adults (ages 18 to 24) during short-term clinical trials.

  • Monitoring Mandate: Healthcare providers must closely monitor all patients initiating doxepin capsules or tablets for emerging suicidal thoughts, worsening of depression, or sudden, unusual shifts in behavior (such as agitation, panic attacks, or mania).
  • Caregiver Education: Families and caregivers must be counseled to watch for these clinical warning signs, particularly during the initial 1 to 2 months of therapy or following any dosage increases. Doxepin is not FDA-approved for pediatric psychiatric populations.

The Anticholinergic and Anti-Adrenergic Burden

  • Anticholinergic Toxicity Symptoms: Due to muscarinic blockade, patients commonly experience dry mouth (xerostomia), blurred vision (cycloplegia), constipation, and urinary retention. These risks are severely amplified in older populations.
  • Orthostatic Hypotension: Alpha-1 adrenergic antagonism can lead to significant drops in blood pressure upon standing, increasing the risk of severe falls.
  • Cardiac Conduction Delays: Like all TCAs, doxepin possesses a quinidine-like effect on the myocardium. It can cause a prolonged QT interval, PR/QRS interval widening, and flattened T-waves. Get a baseline ECG in patients with pre-existing cardiovascular risk factors.

Absolute Contraindications

  • Monoamine Oxidase Inhibitor (MAOI) Co-administration: Concurrent use or use within 14 days of discontinuing an MAOI is strictly contraindicated due to the risk of hyperpyretic crises, severe seizures, and fatal serotonin syndrome.
  • Narrow-Angle Glaucoma: The mydriatic effects of anticholinergic blockade can abruptly increase intraocular pressure, triggering a medical emergency.
  • Severe Urinary Retention: Untreated prostatic hypertrophy or bladder outlet obstruction can worsen to the point of complete mechanical blockage.
  • Acute Post-Myocardial Infarction Setting: Cardiovascular vulnerability and arrhythmia risks during this phase contraindicate the use of any TCA.

Interactions

Critical Drug Interactions

  • CYP2D6 Inhibitors (e.g., Fluoxetine, Paroxetine, Bupropion, Quinidine): These agents severely impair the metabolism of doxepin. Co-administration can drive plasma TCA concentrations to toxic, potentially fatal thresholds, increasing the risk of arrhythmias and seizures.
  • Central Nervous System (CNS) Depressants: Alcohol, benzodiazepines, barbiturates, and opioids synergize with doxepin’s sedating properties, increasing the risk of respiratory depression and profound psychomotor impairment.
  • Sympathomimetics (Epinephrine, Albuterol): Doxepin can dramatically potentiate the pressor response of direct-acting sympathomimetics, leading to acute hypertensive crises.

Special Populations

Geriatric Care

The Beers Criteria explicitly classifies TCAs like doxepin as Potentially Inappropriate Medications for Older Adults. The elderly have a significantly higher vulnerability to anticholinergic side effects, which can induce or worsen cognitive impairment, delirium, severe constipation, and urinary retention. Furthermore, orthostatic hypotension significantly increases the risk of mechanical falls and subsequent fractures. If use is absolutely necessary, clinicians must “start low and go slow,” utilizing alternative agents first.

Pregnancy and Lactation

  • Pregnancy: Doxepin capsules or tablets should only be used during pregnancy if the potential clinical benefit clearly outweighs the risk to the fetus. Some reports have documented withdrawal symptoms (including respiratory distress and irritability) in neonates whose mothers took TCAs up to delivery.
  • Lactation: Doxepin and its active metabolite are excreted into human breast milk. Cases of infant sedation and respiratory depression have been reported; therefore, breastfeeding is generally not recommended for mothers requiring therapeutic doses of doxepin.

Ready to Start Saving?

No one should overpay for safe, effective medication. By cutting out middlemen and working directly with trusted, FDA-approved manufacturers, Invictus offers the same high-quality medicines you’d find at big retail pharmacies—at a fraction of the price.  Whether you choose brand-name or generic, we’ll deliver it quickly, affordably, and right to your door. Maybe that’s why most patients who switch to Invictus never look back.

Frequently Asked Questions (FAQs)

Didn’t see the answers you’re looking for in this article? Check out this comprehensive FAQ for more details.

Administration & Dosage

Uses & Mechanism of Action

Side Effects & Safety

Interactions & Contraindications

Generic & Alternatives

Disclaimer

The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.

Your Prescription

Ready to Fill

Need Help?

Our pharmacists are available 24/7 to answer questions about your medication.